PLUS1
1.31
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Jasper Therapeutics Inc | JSPRW | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.31 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.31 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.31 | USD |
Period:
Draw Mode:
Jasper Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 6.55M | 5.00M | 5.00M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Jasper Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JSPRW Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.25 | 1.37 | 1.18 | 1.32 | 4,303 | 0.06 | 4.8% |
| 1 Month | 1.3319 | 1.66 | 1.02 | 1.33 | 14,183 | -0.0219 | -1.64% |
| 3 Months | 1.73 | 2.24 | 0.976 | 1.71 | 75,048 | -0.42 | -24.28% |
| 6 Months | 1.73 | 2.24 | 0.976 | 1.71 | 75,048 | -0.42 | -24.28% |
| 1 Year | 1.73 | 2.24 | 0.976 | 1.71 | 75,048 | -0.42 | -24.28% |
| 3 Years | 1.73 | 2.24 | 0.976 | 1.71 | 75,048 | -0.42 | -24.28% |
| 5 Years | 1.73 | 2.24 | 0.976 | 1.71 | 75,048 | -0.42 | -24.28% |
Jasper Therapeutics Description
| Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. |
